Cassava Sciences Inc.
SAVA | NASDAQ
$1.32
$0.00 (0.00%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.05 | -4.45 | -1.39 | -2.34 | -7.70 | -4.43 |
PEG Ratio | 0 | 0.06 | -0.05 | -0.02 | -0.03 | 0.53 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.29 | 0.75 | 0.98 | 0.75 | 0.97 | 0.28 |
P/FCF Ratio | -2.91 | -0.93 | -1.64 | -2.11 | -4.69 | -4.73 |
P/OCF Ratio | -2.97 | -0.94 | -1.65 | -2.19 | -8.14 | -4.73 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0 | 0 | 0 |
Quick Ratio | 2.23 | 11.62 | 9.13 | 29.91 | 19.51 | 50.40 |
Current Ratio | 2.23 | 11.62 | 9.13 | 29.91 | 19.51 | 50.40 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -122.27% | -16.71% | -70.72% | -33.51% | -12.75% | -6.87% |
Return on Assets | -76.86% | -15.45% | -64.10% | -32.47% | -12.14% | -6.72% |
Return on Invested Capital | -128% | -97.03% | -77.08% | -35.12% | -12.92% | -6.97% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SAVA